Sukumar Nagendran Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sukumar Nagendran.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sukumar Nagendran. Sukumar Nagendran is a Sr. VP & Chief Medical Officer in AveXis, Inc. ($AVXS) and a Director in Solid Biosciences Inc. ($SLDB) and a Director in Taysha Gene Therapies, Inc. ($TSHA).
Address: C/O AVEXIS, INC. 2275 HALF DAY ROAD, SUITE 160 BANNOCKBURN 60015 IL
Companies in which Sukumar Nagendran is an Insider
AveXis, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Sukumar Nagendran: Sr. VP & Chief Medical Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 15 2018
$AVXS Market Capitalization: $1.59B
$AVXS Previous Close: $58.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Solid Biosciences Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Sukumar Nagendran: Director
Holdings: 34,258 shares
Latest Transaction: Jun 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Taysha Gene Therapies, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Sukumar Nagendran: Director
Holdings: 19,226 shares
Latest Transaction: Jun 21 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Sukumar Nagendran
Sentiment: All, AVXS, SLDB, TSHA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21 2021 | TSHA | Taysha Gene Therap ... | Nagendran Sukumar | Director | Option Exercise | A | 25.04 | 15,500 | 388,120 | 15,500 | |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | Nagendran Sukumar | Director | Option Exercise | C | 0.00 | 17,647 | 0 | 0 | |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | Nagendran Sukumar | Director | Buy | C | 0.00 | 19,226 | 0 | 19,226 | 0 to 19.2 K |
| Sep 25 2020 | TSHA | Taysha Gene Therap ... | Nagendran Sukumar | Director | Option Exercise | A | 20.00 | 31,000 | 620,000 | 31,000 | |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Nagendran Sukumar | Director | Option Exercise | A | 3.03 | 10,000 | 30,300 | 10,000 | |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Nagendran Sukumar | Director | Option Exercise | A | 3.03 | 30,000 | 90,900 | 30,000 | |
| Jul 29 2019 | SLDB | Solid Biosciences ... | Nagendran Sukumar | Director | Grant | A | 4.65 | 32,258 | 150,000 | 34,258 | 2 K to 34.3 K (+1,612.90 %) |